Discounted Cash Flow

Hutchmed (China) Ltd. ADR

HCM · Based on 10 years of SEC filings

—

—

Average annual growth rates

Metric 10-Year 5-Year 3-Year
Sales — — —
Free Cash Flow — — —
Average (FCF & NI) — — —
Net Income — — —

Average annual growth is the mean year-over-year change across each period.

Endpoint CAGR (better for long term trend)

Metric 10-Year 5-Year 3-Year
Sales — — —
Free Cash Flow — — —
Average (FCF & NI) — — —
Net Income — — —

Endpoint CAGR is the compound annual rate from the first to last year in each period.

Projections use average year-over-year growth. Change this in Settings.

Projected growth rate

—

Free cash flow growth —
10-year: — 5-year: — 3-year: —
Averaged growth (FCF & NI) —
10-year: — 5-year: — 3-year: —
Net income growth —
10-year: — 5-year: — 3-year: —
Sales growth (not added to calculations) —
10-year: — 5-year: — 3-year: —

Click a greyed-out slider to switch metrics. Slide between the 10-year, 5-year, and 3-year historic growth rates for FCF, net income, or their average.

%
%

Historical inputs (10 fiscal years)

YEAR Sales Net Income Free Cash Flow Net Margin EPS (diluted)
2016 $216.1m $11.7m $-13.9m 5.4% $0.20
2017 $241.2m (11.6%) $-26.7m (-328.6%) $-14.0m (-0.5%) -11.1% (-304.8%) $-0.43 (-315.0%)
2018 $214.1m (-11.2%) $-74.8m (-179.8%) $-39.2m (-180.8%) -34.9% (-215.2%) $-1.13 (-162.8%)
2019 $204.9m (-4.3%) $-106.0m (-41.7%) $-89.5m (-128.2%) -51.7% (-48.1%) $-0.16 (85.8%)
2020 $228.0m (11.3%) $-125.7m (-18.6%) $-70.0m (21.8%) -55.2% (-6.6%) $-0.18 (-12.5%)
2021 $356.1m (56.2%) $-194.6m (-54.8%) $-220.6m (-215.1%) -54.7% (0.9%) $-0.25 (-38.9%)
2022 $426.4m (19.7%) $-360.8m (-85.4%) $-305.3m (-38.4%) -84.6% (-54.8%) $-0.43 (-72.0%)
2023 $838.0m (96.5%) $100.8m (127.9%) $186.6m (161.1%) 12.0% (114.2%) $0.12 (127.9%)
2024 $630.2m (-24.8%) $37.7m (-62.6%) $-17.4m (-109.3%) 6.0% (-50.2%) $0.04 (-66.7%)
2025 $548.5m (-13.0%) $456.9m (1111.0%) $-78.8m (-352.0%) 83.3% (1291.4%) $0.53 (1225.0%)

Base FCF: — (latest fiscal year)

Discount rate: %

Terminal growth: —

Projection period: — years

Alt A decline yrs:

Alt B total yrs:

Projected cash flows

Year Projected cash flow Discount Factor Present Value

PV of projected FCF: —

Terminal FCF: —

Terminal value: —

PV of terminal value: —

Enterprise value (DCF): —

DCF price per share: —

Current price: —

Alternative DCF Models

Model Fair Value Upside PV(FCFs) PV(Terminal) Total Years
Standard (10yr→TV) ⓘ — — — — 10 + TV
Alt A (Gradual Decline) ⓘ — — — — —
Alt B (30yr Hard Stop) ⓘ — — — N/A —

This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.

+ 10YR Financials Balance Sheet (10YR) Cash Flow (10YR) DCF Model